Cargando…

Assessing brain and biological aging trajectories associated with Alzheimer’s disease

The development of effective treatments to prevent and slow Alzheimer’s disease (AD) pathogenesis is needed in order to tackle the steady increase in the global prevalence of AD. This challenge is complicated by the need to identify key health shifts that precede the onset of AD and cognitive declin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Winnie S., Goetz, Laura H., Schork, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650396/ https://www.ncbi.nlm.nih.gov/pubmed/36389222 http://dx.doi.org/10.3389/fnins.2022.1036102

Ejemplares similares

Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain
por: Riedel, Brandalyn C., et al.
Publicado: (2018)

Impact of hs-CRP concentration on brain structure alterations and cognitive trajectory in Alzheimer’s disease
por: Zhang, Ye, et al.
Publicado: (2023)

Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
por: Stefanovski, Leon, et al.
Publicado: (2021)

APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease
por: Yassine, Hussein N., et al.
Publicado: (2020)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
por: Wang, Ze
Publicado: (2020)

Youthful Processing Speed in Older Adults: Genetic, Biological, and Behavioral Predictors of Cognitive Processing Speed Trajectories in Aging
por: Bott, Nicholas T., et al.
Publicado: (2017)

Increased White Matter Inflammation in Aging- and Alzheimer’s Disease Brain
por: Raj, Divya, et al.
Publicado: (2017)

Does Modulation of an Epigenetic Clock Define a Geroprotector?
por: Schork, Nicholas J., et al.
Publicado: (2022)

Classification-Biased Apparent Brain Age for the Prediction of Alzheimer's Disease
por: Varzandian, Ali, et al.
Publicado: (2021)

Interactions Between Aging and Alzheimer’s Disease on Structural Brain Networks
por: Wu, Zhanxiong, et al.
Publicado: (2021)

Awareness for People With Alzheimer’s Disease: Profiles and Weekly Trajectories
por: Mayelle, Amandine, et al.
Publicado: (2022)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer’s Disease: A Structural Imaging Study
por: Zhao, Weina, et al.
Publicado: (2019)

Wnt Signaling Deregulation in the Aging and Alzheimer’s Brain
por: Palomer, Ernest, et al.
Publicado: (2019)

External Validity of Randomized Controlled Trials on Alzheimer’s Disease: The Biases of Frailty and Biological Aging
por: Canevelli, Marco, et al.
Publicado: (2017)

Biological sources of inflexibility in brain and behavior with aging and neurodegenerative diseases
por: Hong, S. Lee, et al.
Publicado: (2012)

Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
por: Martínez-Pinilla, Eva, et al.
Publicado: (2016)

Comorbidity Trajectories Associated With Alzheimer’s Disease: A Matched Case-Control Study in a United States Claims Database
por: Butler, Lesley M., et al.
Publicado: (2021)

Brain injury, neuroinflammation and Alzheimer's disease
por: Breunig, Joshua J., et al.
Publicado: (2013)

Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model
por: Cheng, Xiao-rui, et al.
Publicado: (2013)

Assessing the Association Between Lead Pollution and Risk of Alzheimer’s Disease by Integrating Multigenomics
por: Li, Chunying, et al.
Publicado: (2022)

Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer’s disease?
por: Kent, Brianne A.
Publicado: (2014)

Accelerated aging-related transcriptome alterations in neurovascular unit cells in the brain of Alzheimer’s disease
por: Zhao, Yan, et al.
Publicado: (2022)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer’s Disease
por: Nugent, Scott, et al.
Publicado: (2020)

Distinctive Temporal Trajectories of Alzheimer’s Disease Biomarkers According to Sex and APOE Genotype: Importance of Striatal Amyloid
por: Kim, Jun Pyo, et al.
Publicado: (2022)

Brain Stimulation for Combating Alzheimer’s Disease
por: Hansen, Niels
Publicado: (2014)

Sialometabolism in Brain Health and Alzheimer’s Disease
por: Rawal, Punam, et al.
Publicado: (2021)

Brain Ischemia as a Prelude to Alzheimer's Disease
por: Pluta, Ryszard, et al.
Publicado: (2021)

Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
por: Lee, Jennifer, et al.
Publicado: (2018)

Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer’s Disease Human Brains
por: Tu, Tian, et al.
Publicado: (2020)

Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer’s Disease
por: Morris, Jill K., et al.
Publicado: (2020)

Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease
por: Jett, Steven, et al.
Publicado: (2022)

Lipopolysaccharide, Identified Using an Antibody and by PAS Staining, Is Associated With Corpora amylacea and White Matter Injury in Alzheimer's Disease and Aging Brain
por: Zhan, Xinhua, et al.
Publicado: (2021)

Identification of Genetic Networks Reveals Complex Associations and Risk Trajectory Linking Mild Cognitive Impairment to Alzheimer’s Disease
por: Strafella, Claudia, et al.
Publicado: (2022)

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms
por: Munro, Catherine E., et al.
Publicado: (2022)

Biological Assessment of a (18)F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer’s Disease as a Potential Astrocytosis Marker
por: Kreimerman, Ingrid, et al.
Publicado: (2019)

Distinct Spontaneous Brain Activity Patterns in Different Biologically-Defined Alzheimer’s Disease Cognitive Stage: A Preliminary Study
por: Zeng, Qingze, et al.
Publicado: (2019)

Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease
por: Baglio, Francesca, et al.
Publicado: (2013)

Diagnosis of Alzheimer’s Disease Using Brain Network
por: Lama, Ramesh Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_im5fhb0pou1paa3gj29tl0n6l1